National Bank of Canada’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

National Bank of Canada’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-200	Closed	-$30.6K	–	2852
2024 Q2	$30.6K	Hold	200	–	–	﹤0.01%	1845
2024 Q1	$29.8K	Hold	200	–	–	﹤0.01%	1916
2023 Q4	$32.1K	Hold	200	–	–	﹤0.01%	1900
2023 Q3	$28.9K	Hold	200	–	–	﹤0.01%	1944
2023 Q2	$30.5K	Hold	200	–	–	﹤0.01%	1912
2023 Q1	$31K	Hold	200	–	–	﹤0.01%	1850
2022 Q4	$30.8K	Hold	200	–	–	﹤0.01%	1893
2022 Q3	$26K	Hold	200	–	–	﹤0.01%	1937
2022 Q2	$27K	Hold	200	–	–	﹤0.01%	1967
2022 Q1	$30K	Hold	200	–	–	﹤0.01%	2031
2021 Q4	$32K	Buy	+200	New	+$32.3K	﹤0.01%	2021

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

National Bank of Canada's FBT Position: Q3 2024 in Review

National Bank of Canada sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2024, closing a stake of 200 shares — an estimated $30.6K sold.

National Bank of Canada first reported a position in FBT in Q4 2021 and held it in 11 quarters. The position peaked at $32.1K in Q4 2023. 257 funds tracked by Wall St. Rank hold FBT as of Q3 2024.

National Bank of Canada reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2024 after selling out during the quarter.
National Bank of Canada sold 200 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2024, an estimated $30.6K.
National Bank of Canada first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and held it in 11 quarters.
National Bank of Canada's First Trust NYSE Arca Biotechnology Index Fund position peaked at $32.1K in Q4 2023.
257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2024.

Based on National Bank of Canada's 13F filing for Q3 2024, filed 12 Nov 2024.